Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 08/27/2024 10:52:21 AM
Board Marks: 278
Posts Today: 0
Board Views Today: 1384
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
70987
Found this post on another site. Am currently
(7)
petemantx
12/30/2021 4:49:55 PM
70982
Hope everyone had a Merry Christmas and is
(7)
scgmck1
12/29/2021 10:25:24 PM
70980
Initially I was very disturbed with the PR
(8)
petemantx
12/27/2021 8:38:39 PM
70979
As frustrations mount over the need for, what
(2)
Commando911
12/27/2021 12:52:02 AM
70978
So if you have migraines or certain heart
(3)
Drano
12/27/2021 12:07:13 AM
70977
Ritonavir, part of part of Pfizer's covid pill
(5)
farrell
12/26/2021 11:43:01 PM
70976
Great post farrell. We have all read about safety
(6)
Mo
12/26/2021 11:49:20 AM
70975
At this point none of the other antiviral drugs
(11)
farrell
12/26/2021 10:59:11 AM
70972
Thanks and same to you and the board as well.
(3)
Kelt
12/25/2021 3:14:01 PM
70968
Second the motion. Merry Christmas and let's hope
(5)
Drano
12/25/2021 11:02:42 AM
70967
Merry Christmas to you and all who
(5)
someconcerns
12/25/2021 6:31:36 AM
70966
Merry Christmas, folks!
(5)
Commando911
12/24/2021 10:56:00 PM
70965
Maybe Leo will apply for a NIIMBL grant from the
Commando911
12/23/2021 10:04:23 AM
70961
Response to a post on another board. Post:
(3)
Kelt
12/21/2021 6:03:41 PM
70959
Good information. The "broad spectrum" potential
bandg
12/21/2021 9:14:37 AM
70958
Links:
(2)
farrell
12/21/2021 9:05:24 AM
70956
The multi-identity just wants to soft bash. But
(3)
Drano
12/20/2021 4:29:32 PM
70955
The "Fat Lady" hasn't sung yet on the P2 results
(5)
Kelt
12/20/2021 3:49:14 PM
70954
Brilacidin phase 2 test suggested they did not
(4)
airplaneguy
12/20/2021 3:06:09 PM
70953
With Regeneron's covid antiviral "antibiotic"
(12)
farrell
12/19/2021 12:10:14 AM
70952
IPIX has a distinct advantage over Galera and
(4)
bandg
12/16/2021 1:50:16 PM
70949
Nice soft-bashing. Galera's drug initially failed
(6)
Drano
12/16/2021 2:22:45 AM
70948
Lilly's Mirikizumab for UC. Galera's GC4419 for
(3)
bandg
12/15/2021 8:41:20 PM
70947
This is a fascinating read. it's no wonder that
(6)
Fit007
12/15/2021 8:00:18 AM
70946
GREAT Brilacidin link from another site. True
(5)
petemantx
12/14/2021 8:10:18 PM
70945
Agreed.
bandg
12/14/2021 6:33:15 PM
70944
That's quite the endorsement of B....that alone
(7)
Chemdeps
12/14/2021 5:57:12 PM
70943
Current university article with mention of
(4)
bandg
12/14/2021 5:34:30 PM
70941
Russian State Register of Medicines status,
(1)
crashco
12/13/2021 9:44:42 AM
70936
Thats easy, Drano. Because theres a whole
(10)
scgmck1
12/08/2021 9:50:42 PM
70934
Glad to see that the multi-identities are
(3)
Drano
12/08/2021 4:05:40 PM
70932
Seems logical that they would continue until
(1)
bandg
12/08/2021 3:09:05 PM
70931
hahaha he's having to sign in under several
(3)
Drano
12/08/2021 3:01:18 PM
70930
The big question I have is why multi-identities
(5)
Drano
12/08/2021 1:40:43 PM
70929
So the big question I have is...are doctors still
(3)
Chemdeps
12/08/2021 11:52:36 AM
70928
On what? Whom are you speaking
(2)
scgmck1
12/07/2021 9:28:33 PM
70927
$IPIX ICYMI
(1)
TonyCorvette
12/07/2021 7:38:14 AM
70925
I'd think any compassionate use analysis could
(1)
bandg
12/06/2021 7:03:33 PM
70923
Easy to find as to Remdesivir recommended
(1)
bandg
12/06/2021 5:39:36 PM
70922
Attached is an article I found online just now by
(3)
petemantx
12/06/2021 4:37:43 PM
70920
Pete, I believe the Yahoo author is incorrect
(11)
Mo
12/06/2021 1:24:24 PM
70915
I found this link on another site and what
(5)
petemantx
12/05/2021 9:25:04 AM
70914
I'd be bettinglarge on that one !!
(3)
Kelt
11/30/2021 10:20:53 PM
70912
How amusing that the scum multiple identity
(8)
Drano
11/30/2021 10:02:32 AM
70910
How far will scum go to manipulate stock price?
(5)
Drano
11/30/2021 9:48:44 AM
70909
Polymedix's study of its defensin mimetics
(6)
farrell
11/28/2021 12:20:39 PM
70908
Thanks for posting this. Brilacidin performs
KDPMD
11/27/2021 8:02:16 PM
70907
Russian clinical trial past fraud
djs7
11/27/2021 7:12:48 PM
70906
Attached link quite interesting for a number of
(8)
petemantx
11/27/2021 1:56:52 PM
70905
The purported "AlanC" who just posted is NOT the
(10)
Drano
11/23/2021 1:54:06 PM
< Previous
Next >
Recent Articles
RCG Global Services Strengthens Offerings with Aethereus Deal
Major Brokerages Predict 25 Bps Rate Cuts from Fed in November
Top Financial Stocks Positioned for Innovation in the Coming Years
Jim Rickards' Essential Strategies for Wealth Protection Amid Chaos
Alliance Trust PLC Reports Latest Net Asset Values for Investors
Oatly Group Prepares to Announce Q3 2024 Financial Insights
CytoMed Therapeutics Advances CAR-T Trials with Major Grant
Exciting Launch of Charlotte’s Web CBD Gummies in Canada
Microbix Unveils Innovative HSV Control Solution at EMMD
Beasley Broadcast Group Completes Note Exchange Successfully
AIRSUPRA® Significantly Lowers Severe Asthma Risks in Trials
Exploring New Frontiers in Cancer Therapy with UNO
Billionaires Target High-Growth FAANG Stocks for Success
Marti Technologies Launches Ride-Hailing Monetization Strategy
Unveiling the Potential of GT-02287 in Parkinson's Research
Discover Top ETFs for Smart Investment Strategies
Bruker Unveils OptoVolt for Enhanced Neuroscience Research
InspireMD's Innovative CGuard Study Receives FDA Approval
Cleveland-Cliffs Hosts Key Government Officials for Steel Industry
Mural Oncology Showcases Innovations in Immuno-Oncology Research
ViiV Healthcare Expands Access to Long-Acting HIV Prevention
Foremost Clean Energy Partners with Denison Mines for Uranium Exploration
Judo Bio Advances Gene Therapy Research for Kidney Treatment
Chris Akrimi's New Role at NuORDER by Lightspeed Enhances Growth
GXO Logistics Plans Earnings Call for Third Quarter 2024
Oak Hill Bio Welcomes New Executive Leadership and Board Members
Perspective Therapeutics Engages in Key Oncology Events Ahead
Energy Recovery Announces Upcoming Financial Results and Webinar
Generations Bancorp NY, Inc. Joins OTCQX for Enhanced Trading
Consensus Cloud Solutions Plans Exciting Q3 Earnings Call
Gray Media Expands Reach with New Local News Live Apps
BPGbio Teams with Oxford University to Propel Protein Research Forward
Rubicon Organics Unveils Comprehensive Sustainability Report
Scholar Rock Celebrates Phase 3 Success for SMA Treatment
NIU Technologies Unveils KQi 100F Electric Scooter at Expo
Judo Bio Marks $100M Financing and Welcomes Rajiv Patni as CEO
Virios and Wex Join Forces to Launch Dogwood Therapeutics
Laser Photonics Expands to 50,000 sq. ft. Facility for Growth
Blue Owl Capital's Strategic Move to Enhance Digital Infrastructure
Chimney and Jack Henry Join Forces to Enhance Homeowner Engagement
New Era of Flavor: Clark Foods Launches in the U.S. Market
Leadership Expansion for Vantage Data Centers in APAC Region
Welltower Sets Earnings Release Date for Q3 2024 Results
Transforming Audits: The Role of AI and Human Expertise
Situ Ve Promotes Respect and Empathy in Romantic Relationships
Jetcraft Strengthens EMEA Sales Team with New Director Role
Powerfleet Invites Investors to Day of Insights and Growth
Kinaxis Strengthens Ono Pharmaceutical's Supply Chain Strategy
Streamlining IT Procurement: SysAid Launches on AWS Marketplace
Mason Capital Management Consortia's Strategic Acquisition of CB&I
EVERSANA Strengthens Global Presence with New Office in Berlin
Dundee Precious Metals Reports Robust Production Figures
Capital Square Achieves Remarkable 136.42% Return on Investment
Global Markets Update: Insights into Recent Trends and Movements
Five Star Franchising Celebrates Success with Top Ten Ranking
Veralto Strengthens Food Safety Solutions with TraceGains Purchase
AerCap Achieves Major Milestones in Q3 with $10.5 Billion Financing
ROSHI Insights: Future of Digital Lending and Growth Trends
Tint World® Celebrates Achievement with Franchise Times Top 400
Creekside Behavioral Health Celebrates Six Years of Care
Enbridge and Microsoft Partner for AI Innovations in Energy Sector
Glassbeam Partners with Veterans Health Administration for Better Care
Harts Plumbers Partners with Seahawks to Enhance Fan Experience
Insight into Copper Demand Amidst Electric Vehicle Evolution
Discover Magewell's Latest Enhancements for Streaming Ease
Apollo's $3.6 Billion Purchase of Barnes Group Explained
Albemarle Corporation's Strategic Moves to Enhance Efficiency
Keeper Security's Cybersecurity Action Month: Focus on Phishing
Roth/MKM Affirms Buy Rating as Hasbro Prepares for Growth
The Life-Changing Power of Plasma Donation Awareness Campaign
Genco Shipping Expands Fleet with New Capesize Vessel Acquisition
Mattel's Strategic Insights Amidst Analyst Concerns
Blue Owl Capital's Strategic $1 Billion Acquisition of IPI Partners
Duckhorn Portfolio Joins Forces with Butterfly Equity in Major Deal
Enbridge and Microsoft Join Forces to Enhance AI Operations
Scholar Rock Advances Apitegromab in SMA Treatment Journey
Surge in U.S. Dividend ETFs Receives Investor Spotlight
Market Trends Shift Amid Fed Rate Speculations This Week
Equinor Expands Influence with Strategic Orsted Stake Purchase
CAMP4 Therapeutics Targets $283 Million Valuation for IPO
Exciting Drilling Results from Solaris Resources at Warintza
Can-Fite Unveils Upcoming Investor Webinar: What to Expect
Innovative Goldfish Developer Devo Makes Waves with OnlyFins
RTI Surgical's Acquisition of Collagen Solutions: A Game Changer
Exploring the Expanding 9 Decanoic Acid Methyl Ester Market
How Autopay by RentRedi Boosts Landlord Cash Flow Effectively
Exploring Dental Consumables: Market Growth and Trends Ahead
Madison Metals' Insider Purchases Signal Strong Market Trust
Genco Shipping Expands Fleet with Modern Capesize Vessel
NuScale Power's Upcoming Q3 2024 Results and Conference Call Insights
SpaceX's Falcon 9 Set for Important ESA Hera Mission Launch
UAE Embedded Finance Market Set for Dramatic Growth by 2029
Radisson Mining Welcomes David Ross and Expands Exploration Efforts
Mark Cuban's Insight on Tariffs and the Future of U.S. Manufacturing
Market Outlook: Key Economic Indicators on the Horizon
Three Undervalued Financial Stocks Poised for Growth
Food and Beverage Metal Cans Market Projected Growth by 2029
CeriBell, Inc Targets $14-$16 per Share for New IPO
GFL Environmental and OPAL Fuels Unveil New RNG Facility
Upcoming Economic Reports and Earnings Season Insights